Trovagene and US Oncology Research have joined forces to examine the utility of quantitative urine-based KRAS mutation detection and monitoring in pancreatic cancer patients.
Read MoreThe American Congress of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have jointly issued new guidelines recommending the use of chromosomal microarray analysis in pregnancies with fetal abnormalities.
Read More
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
Read MoreOn the heels of a CMS decision to reduce reimbursement for BRCA testing by roughly 50%, Myriad Genetics is getting a closer look from investors, and a downgrade from analysts.
Read MoreThe US Preventive Services Task Force has issued a final recommendation on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women.
Read More